This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Albert M. Maguire, MD; Jean Bennett, PhD, MD
Baltimore

Arch Ophthalmol. 1988;106(6):718-719.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Fluorescein angiography is a widely utilized diagnostic technique, with few reported complications. Systemic administration of fluorescein sodium dye, however, is associated with a small but definite risk of serious systemic reactions, including anaphylaxis, cardiac arrest, myocardial infarction, and death.¹ In addition, a fluorescein-induced phototoxic reaction has been recently described by Kearns et al² in the pediatric literature. They described a premature infant undergoing phototherapy for hyperbilirubinemia who developed a severe bullous skin eruption shortly after administration of fluorescein for angiography. Kearns et al suggested that the mechanism of phototoxicity is related to the generation of superoxide anions by exposure of fluorescein to light at 450 to 550 nm during phototherapy.

It was particularly interesting to us to learn of this report of fluorescein-induced phototoxicity related to phototherapy for hyperbilirubinemia. We recently encountered a 29-year-old woman who developed acute loss of central vision shortly after premature . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?